Date Published : 2024/05/24 | Article

Eastern Cape's Multi-Million Rand Investment Boosts Cancer Treatment Facilities

Eastern Cape's Multi-Million Rand Investment Boosts Cancer Treatment Facilities

The healthcare facilities in the Eastern Cape have received a significant boost with the unveiling of over R200 million worth of cutting-edge equipment to enhance cancer treatment capabilities. Spearheaded by the Department of Health, this investment signifies a pivotal step towards revolutionizing oncological care in the province.

The oncology units at Frere Hospital in East London and Livingstone Hospital in Gqeberha are at the forefront of this initiative. Each facility now boasts a formidable arsenal of lifesaving equipment worth over R100 million, including a linear accelerator (Linac), a CT scanner, and a fluoroscopy unit.

Health MEC Nomakhosazana Meth has emphasized the importance of early detection and treatment of cancer. "Through this equipment, we ensure we can successfully treat cancer patients. However, we urge people to seek medical attention if they suspect they might not be well so that if they have cancer, it can be picked up early and treated before it spreads," Meth stated.

The new Linac machine will provide advanced external beam radiation treatments, complementing other treatment options such as surgery and chemotherapy. The CT scanner and fluoroscopy unit will enhance the oncology unit's diagnostic capabilities, allowing for more precise and timely treatment planning.

In addition to this investment, a state-of-the-art oncology unit, with a substantial investment of R412 million, is currently under construction at Nelson Mandela Academic Hospital in Mthatha. This unit is expected to serve the eastern part of the province, significantly improving access to cancer care.

These initiatives are part of the Department of Health's broader efforts to improve health and care services across the province by implementing the National Health Insurance (NHI). The comprehensive approach ensures that all patients, regardless of location, have access to high-quality cancer treatment.